Histopathologic clues for the diagnosis of Wiesner nevus

Journal of the American Academy of Dermatology

Volumn 70, Issue 3, 2014, Pages 549-554

  Llamas Velasco, Mar ^a   Pérez Gónzalez, Yosmar Carolina ^a   Requena, Luis ^b   Kutzner, Heinz ^c  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b Department of Dermatology of Fundación Jimenez Diaz ^*  (Spain)

^c Dermatopathologie Friedrichshafen   (Germany)

Author keywords

B raf; BAP1 protein; epithelioid and spindle cell; human; nevus; proto oncogene proteins

Indexed keywords

B-RAF; BAP1 PROTEIN; EPITHELIOID AND SPINDLE CELL; HUMAN; NEVUS; PROTO-ONCOGENE PROTEINS;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84894045002     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.10.032     Document Type: Article

References (14)

1. T. Wiesner, A.C. Obenauf, R. Murali, I. Fried, K.G. Griewank, and P. Ulz et al. Germline mutations in BAP1 predispose to melanocytic tumors Nat Genet 43 2011 1018 1021
2. A.M. Goldstein Germline BAP1 mutations and tumor susceptibility Nat Genet 43 2011 925 926
3. M. Carbone, H. Yang, H.I. Pass, T. Krausz, J.R. Testa, and G. Gaudino BAP1 and cancer Nat Rev Cancer 13 2013 153 159
4. M. Cheung, J. Talarchek, K. Schindeler, E. Saraiva, L.S. Penney, and M. Ludman et al. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma Cancer Genet 206 2013 206 210
5. A. Dey, D. Seshasayee, R. Noubade, D.M. French, J. Liu, and M.S. Chaurushiya et al. Loss of the tumor suppressor BAP1 causes myeloid transformation Science 337 2012 1541 1546
6. R. Murali, T. Wiesner, and R.A. Scolyer Tumors associated with BAP1 mutations Pathology 45 2013 116 126
7. D.W. Henderson, G. Reid, S.C. Kao, N. van Zandwijk, and S. Klebe Challenges and controversies in the diagnosis of malignant mesothelioma, part 2: malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA J Clin Pathol 92 2013 974 980
8. T. Popova, L. Hebert, V. Jacquemin, S. Gad, V. Caux-Moncoutier, and C. Dubois-d'Enghien et al. Germline BAP1 mutations predispose to renal cell carcinomas Am J Hum Genet 92 2013 974 980
9. C. Ribeiro, S. Campelos, C.S. Moura, J.C. Machado, A. Justino, and B. Parente Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation Ann Oncol 24 2013 2147 2150
10. G.V. Long, J.S. Wilmott, D. Capper, M. Preusser, Y.E. Zhang, and J.F. Thompson et al. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma Am J Surg Pathol 37 2013 61 65
11. T. Wiesner, I. Fried, P. Ulz, E. Stacher, H. Popper, and R. Murali et al. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations J Clin Oncol 30 2012 e337 e340
12. T. Wiesner, R. Murali, I. Fried, L. Cerroni, K. Busam, and H. Kutzner et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression Am J Surg Pathol 36 2012 818 830
13. K.J. Busam, M. Wanna, and T. Wiesner Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome JAMA Dermatol 149 2013 335 339
14. K.J. Busam, J. Sung, T. Wiesner, A. von Deimling, and A. Jungbluth Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes Am J Surg Pathol 37 2013 193 199